Evidence map›Paper›PMID 24647709›Full record

ReviewAmerican journal of physiology. Renal physiology2014

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

Kirk P Conrad, John M Davison

Abstract readComparative StudyReview
In one paragraph

Review in American journal of physiology. Renal physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Placental and Renal Pathways Underlying Pre-Eclampsia.International journal of molecular sciences · 2024
    Review
  11. Non-obstetric Acute Abdomen in Pregnancy: a Review of Literature.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Observational
  16. Review
  17. Article
  18. Anatomical and physiological alterations of pregnancy.Journal of pharmacokinetics and pharmacodynamics · 2020
    Review
  19. New targets for overactive bladder-ICI-RS 2109.Neurourology and urodynamics · 2020
    Review
  20. Ocular vascular changes during pregnancy: an optical coherence tomography angiography study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Kirk P ConradDepartments of Physiology and Functional Genomics and Obstetrics and Gynecology, D. H. Barron Reproductive and Perinatal Biology Research Program, University of Florida College of Medicine, Gainesville, Florida; and kpconrad@ufl.edu.
John M DavisonInstitute of Cellular Medicine and Royal Victoria Infirmary, Newcastle University and Newcastle Hospitals National Health Service Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Florida College · USNewcastle University · GB

Funding

Mechanisms & Consequences of Vascular Adaptations in Pregnancies Conceived by ARTP01HD065647 · NICHD · UNIVERSITY OF FLORIDA · PI CONRAD, KIRK P · 2011 to 2016
$6.1M
Relaxin: The 'Elusive'Vasodilator of PregnancyR01HL067937 · NHLBI · UNIVERSITY OF FLORIDA · PI CONRAD, KIRK P · 2001 to 2009
$2.2M
Mechanisms of Vasodilation in PregancyR01DK063321 · NIDDK · UNIVERSITY OF FLORIDA · PI CONRAD, KIRK P · 2002 to 2005
$1.1M
NITRIC OXIDE AND MATERNAL HEMODYNAMICS IN PREGNANCYR01HD030325 · NICHD · UNIVERSITY OF NEW MEXICO · PI CONRA, KIRK P · 1994 to 2001
$473k
Mechanisms of Renal Vasodilation by RelaxinR21HL093605 · NHLBI · UNIVERSITY OF FLORIDA · PI CONRAD, KIRK P · 2009 to 2010
$423k
PROSTAGLANDINS, ANGIOTENSIN, NUCLEOTIDES IN PREGNANCYR01HL038076 · NHLBI · DARTMOUTH COLLEGE · PI CONRA, KIRK P · 1987 to 1989
–
GLOMERULAR FUNCTION/BLOOD PRESSURE--PREGNANCYK11HD000662 · NICHD · DARTMOUTH COLLEGE · PI CONRA, KIRK P · 1985 to 1989
–
NHLBI NIH HHS R01-HL-038076NHLBI NIH HHS R01-HL-067937NHLBI NIH HHS R21-HL-093605NICHD NIH HHS K11-HD-00662NICHD NIH HHS P01-HD-065647NICHD NIH HHS R01-HD-030325NIDDK NIH HHS R01-DK-063321
6 · The paper itself

Abstract

During the first trimester of human pregnancy, the maternal systemic circulation undergoes remarkable vasodilation. The kidneys participate in this vasodilatory response resulting in marked increases in renal plasma flow (RPF) and glomerular filtration rate (GFR). Comparable circulatory adaptations are observed in conscious gravid rats. Administration of the corpus luteal hormone relaxin (RLN) to nonpregnant rats and humans elicits vasodilatory changes like those of pregnancy. Systemic and renal vasodilation are compromised in midterm pregnant rats by neutralization or elimination of circulating RLN and in women conceiving with donor eggs who lack a corpus luteum and circulating RLN. Although RLN exerts both rapid (minutes) and sustained (hours to days) vasodilatory actions through different molecular mechanisms, a final common pathway is endothelial nitric oxide. In preeclampsia (PE), maternal systemic and renal vasoconstriction leads to hypertension and modest reduction in GFR exceeding that of RPF. Elevated level of circulating soluble vascular endothelial growth factor receptor-1 arising from the placenta is implicated in the hypertension and disruption of glomerular fenestrae and barrier function, the former causing reduced Kf and the latter proteinuria. Additional pathogenic factors are discussed. Last, potential clinical ramifications include RLN replacement in women conceiving with donor eggs and its therapeutic use in PE. Another goal has been to apply knowledge gained from investigating circulatory adaptations in pregnancy toward identifying and developing novel therapeutic strategies for renal and cardiovascular disease in the nonpregnant population. So far, one candidate to emerge is RLN and its potential therapeutic use in heart failure.

Indexed as

AnimalsFemaleGlomerular Filtration RateHumansKidneyModels, AnimalPre-EclampsiaPregnancyPregnancy, AnimalRatsRegional Blood FlowRelaxinRenal CirculationRenal Plasma FlowVasodilationRelaxinassisted reproductive technologyglomerular endotheliosisglomerular filtrationheart failurenitric oxideosmoregulationrelaxinrenal hemodynamicssoluble vascular endothelial growth factor receptor-1

Identifiers

PMID24647709
PMCPMC4024736
OpenAlexW2157442738

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.